Row 21584

Row ID: 21584 | Dataset Entry | Axioma AXP Content Repository

Content Data

This page contains data entry 21584 from the Axioma AXP content repository. The structured data below represents the complete record for this entry.

The ETF, ticker **$OZEM**, is set to launch this week per [CNBC](https://www.cnbc.com/video/2024/05/20/roundhill-to-launch-active-weight-loss-etf.html) and [Roundhill](https://www.roundhillinvestments.com/etf/ozem/).

**From Roundhill** "weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry"

The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM pursues its investment objective by seeking to provide exposure to companies involved in the development of pharmaceutical drugs and/or supplements that can be utilized to help individuals lose weight, maintain an ideal weight, and/or maintain body composition during weight loss. OZEM is an actively-managed ETF.

Top holdings? You guessed it — Lilly and Novo Nordisk. Check out the top holdings and more here: [https://www.roundhillinvestments.com/etf/ozem/](https://www.roundhillinvestments.com/etf/ozem/)

FieldValue
text The ETF, ticker **$OZEM**, is set to launch this week per [CNBC](https://www.cnbc.com/video/2024/05/20/roundhill-to-launch-active-weight-loss-etf.html) and [Roundhill](https://www.roundhillinvestments.com/etf/ozem/). **From Roundhill** "weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry" The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM pursues its investment objective by see…
label r/wallstreetbets
dataType post
communityName r/wallstreetbets
datetime 2024-05-21
username_encoded Z0FBQUFBQm5Lak1BVTE2Y2tMZU5CaVliaTJ6YWduRWxvMDBtUFh4X2kyd3BrNTBPNkIwQUhBMGQwUTl2YWFjRHRicmpwLWpKeElRekhmam1Za2U2RzBRU3lORm5MZ3kyMHc9PQ==
url_encoded Z0FBQUFBQm5Lak9QQlpmaEIySmR6YlNobjBWVXE1VU16WkJMemRlMXJEbXo5eU55bmNHdVJKS1NQOE1xY2RYa1NSQVJsenBVRjl6RW9TYldVR0xjQWk1Y242NWVSRmowMFduQ25ROGhtLVA0aUtvRWtOeVlWdEpCYlBZcWhmeEd2QmRYSlFYZ1VESU9HWnR4cFp2QzhTZXYzOWJQbWpWc21HczN0VVBqZkh2TG5fUGlfV09BVHh2X2w2ZXd4RVk4dkRBaEppWTYwZUFU

Raw Record

{
  "text": "The ETF, ticker **$OZEM**, is set to launch this week per [CNBC](https://www.cnbc.com/video/2024/05/20/roundhill-to-launch-active-weight-loss-etf.html) and [Roundhill](https://www.roundhillinvestments.com/etf/ozem/).\n\n**From Roundhill** \"weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry\"\n\nThe Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM pursues its investment objective by seeking to provide exposure to companies involved in the development of pharmaceutical drugs and/or supplements that can be utilized to help individuals lose weight, maintain an ideal weight, and/or maintain body composition during weight loss. OZEM is an actively-managed ETF.\n\n  \nTop holdings? You guessed it — Lilly and Novo Nordisk. Check out the top holdings and more here: [https://www.roundhillinvestments.com/etf/ozem/](https://www.roundhillinvestments.com/etf/ozem/)",
  "label": "r/wallstreetbets",
  "dataType": "post",
  "communityName": "r/wallstreetbets",
  "datetime": "2024-05-21",
  "username_encoded": "Z0FBQUFBQm5Lak1BVTE2Y2tMZU5CaVliaTJ6YWduRWxvMDBtUFh4X2kyd3BrNTBPNkIwQUhBMGQwUTl2YWFjRHRicmpwLWpKeElRekhmam1Za2U2RzBRU3lORm5MZ3kyMHc9PQ==",
  "url_encoded": "Z0FBQUFBQm5Lak9QQlpmaEIySmR6YlNobjBWVXE1VU16WkJMemRlMXJEbXo5eU55bmNHdVJKS1NQOE1xY2RYa1NSQVJsenBVRjl6RW9TYldVR0xjQWk1Y242NWVSRmowMFduQ25ROGhtLVA0aUtvRWtOeVlWdEpCYlBZcWhmeEd2QmRYSlFYZ1VESU9HWnR4cFp2QzhTZXYzOWJQbWpWc21HczN0VVBqZkh2TG5fUGlfV09BVHh2X2w2ZXd4RVk4dkRBaEppWTYwZUFU"
}
Explore Dataset Explore Row

Entry Information